Molecular Biology Of Varicella Zoster Virus Infection
水痘带状疱疹病毒感染的分子生物学
基本信息
- 批准号:8946264
- 负责人:
- 金额:$ 20.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseAntibodiesAntigensApoptosisBiological AssayCaspaseCell CycleCell Cycle ProgressionCell DeathCell ProliferationCell divisionCellsChickenpoxChickenpox VaccineDNA DamageDNA Double Strand BreakDNA RepairDiagnosticFluorescent Antibody TechniqueGenesGoalsHerpes zoster diseaseHerpesvirus Type 3Mammalian CellMediator of activation proteinMembraneMolecular BiologyNeuronsPathogenesisPathway interactionsPersonsPhosphorylationPrevention programProteinsRecruitment ActivityReporterSensitivity and SpecificitySerumSignal PathwaySignal TransductionSignaling ProteinSiteSystemVaccinesViral ProteinsVirusVirus DiseasesVirus Replicationcell typegenome-wideimprovedkeratinocyteknock-downoverexpressionreceptorresponsetissue/cell culture
项目摘要
Varicella-zoster virus (VZV) causes chickenpox and shingles. Virus infection of cells is known to trigger several signaling pathways that are important for cell proliferation and prevention of programmed cell death (also known as apoptosis). We have used a virus genome wide approach to identify functions of VZV proteins. Nearly all of the 71 VZV genes were individually expressed in tissue culture cells along with a reporter system that responds to specific signaling proteins. Using this approach, last year we showed that VZV ORF12 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway (a cell signaling pathway) to regulate cell cycle progression (important for cell division). Since VZV replicates in both dividing (keratinocytes) and non-dividing (neurons) cells, the ability of the VZV ORF12 protein to regulate the cell cycle is likely important for VZV replication in various cell types in the body.
This year we found that VZV triggers the phosphorylation of two proteins, Bim and BAD, that are important for inducing programmed cell death (also known as apoptosis). Phosphorylation of these proteins reduces their ability to cause cell death. VZV-infected cells that were knocked-down for expression of Bim survived longer and produced higher titers of virus compared with wild-type cells infected with the virus. In contrast, VZV-infected cells that over-expressed Bim showed reduced survival and reduced virus replication. Inhibition of caspase activity in cells overexpressing Bim restored levels of virus replication to those seen in wild-type cells.
Mammalian cells activate DNA damage response pathways in response to virus infections. H2AX and ATM are activated and recruited to the site of double-stranded DNA breaks and are important for repairing the DNA. We found that VZV-infected cells had elevated levels of phosphorylated H2AX and ATM compared with uninfected cells. Cells infected with VZV deleted for ORF61 or ORF63, but not ORF67, had higher levels of phosphorylated H2AX and ATM compared with cells infected with wild-type virus.
We have also been developing a more sensitive assay to detect antibody to VZV in recipients of the varicella vaccine. We are comparing our assay using sera from persons who received the vaccine, with results obtained from the fluorescent antibody to membrane antigen (FAMA) assay, to determine the sensitivity and specificity of our assay.
水痘带状疱疹病毒(VZV)引起水痘和带状疱疹。已知细胞的病毒感染会触发几种对细胞增殖和预防程序性细胞死亡(也称为凋亡)至关重要的信号通路。我们已经使用了病毒基因组广泛的方法来识别VZV蛋白的功能。几乎所有71个VZV基因都在组织培养细胞中单独表达,以及对特定信号蛋白响应的报告基因。使用这种方法,去年我们表明,VZV ORF12蛋白激活磷脂酰肌醇3-激酶(PI3K)/AKT途径(细胞信号通路)以调节细胞周期进程(对细胞分裂很重要)。 由于VZV在分裂(角质形成细胞)和非分裂(神经元)细胞中都复制,因此VZV ORF12蛋白调节细胞周期的能力对于体内各种细胞类型的VZV复制可能很重要。
今年,我们发现VZV触发了两种BIM和坏蛋白的磷酸化,这对于诱导程序性细胞死亡(也称为凋亡)很重要。 这些蛋白质的磷酸化降低了它们引起细胞死亡的能力。 与感染了病毒感染的野生型细胞相比,被撞倒以表达BIM的VZV感染细胞存活更长,并且产生了更高的病毒滴度。 相比之下,过表达BIM的VZV感染细胞显示存活率降低和病毒复制降低。 抑制过表达BIM的细胞中caspase活性的抑制,使病毒复制水平恢复了野生型细胞中的病毒复制水平。
哺乳动物细胞激活DNA损伤反应途径,以响应病毒感染。 H2AX和ATM被激活并招募到双链DNA断裂部位,对于修复DNA很重要。 我们发现,与未感染的细胞相比,VZV感染的细胞的磷酸化H2AX和ATM水平升高。 与感染了野生型病毒的细胞相比,被VZV感染的细胞被删除的ORF61或ORF63而不是ORF67的细胞具有较高水平的磷酸化H2AX和ATM。
我们还一直在开发一种更敏感的测定法,以检测水痘疫苗接受者中对VZV的抗体。我们正在使用接收疫苗的人的血清进行比较,并从荧光抗体到膜抗原(FAMA)测定法获得结果,以确定我们的测定的敏感性和特异性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey Cohen其他文献
Jeffrey Cohen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey Cohen', 18)}}的其他基金
Serologic studies of persons with COVID-19 infection
COVID-19 感染者的血清学研究
- 批准号:
10272254 - 财政年份:
- 资助金额:
$ 20.24万 - 项目类别:
Pathogenesis and Chemotherapy of Herpesvirus Infection
疱疹病毒感染的发病机制及化疗
- 批准号:
7592112 - 财政年份:
- 资助金额:
$ 20.24万 - 项目类别:
Development Of Vaccines For Genital Herpes Simplex Infection
生殖器单纯疱疹感染疫苗的开发
- 批准号:
8555777 - 财政年份:
- 资助金额:
$ 20.24万 - 项目类别:
Molecular Biology Of Varicella Zoster Virus Infection
水痘带状疱疹病毒感染的分子生物学
- 批准号:
8555759 - 财政年份:
- 资助金额:
$ 20.24万 - 项目类别:
Development Of Vaccines For Genital Herpes Simplex Infection
生殖器单纯疱疹感染疫苗的开发
- 批准号:
7964296 - 财政年份:
- 资助金额:
$ 20.24万 - 项目类别:
Molecular Biology Of Varicella Zoster Virus Infection
水痘带状疱疹病毒感染的分子生物学
- 批准号:
7964260 - 财政年份:
- 资助金额:
$ 20.24万 - 项目类别:
Development Of Vaccines For Genital Herpes Simplex Infection
生殖器单纯疱疹感染疫苗的开发
- 批准号:
8745313 - 财政年份:
- 资助金额:
$ 20.24万 - 项目类别:
Molecular Biology Of Varicella Zoster Virus Infection
水痘带状疱疹病毒感染的分子生物学
- 批准号:
10692020 - 财政年份:
- 资助金额:
$ 20.24万 - 项目类别:
相似国自然基金
抗变构/单体形式的C反应蛋白关键抗原表位199-206抗体在狼疮性肾炎小管间质病变中的作用机制及其靶向治疗研究
- 批准号:82300829
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
原位疫苗新策略:抗体偶联仿生ROS纳米酶增强巨噬细胞吞噬及抗原交叉呈递效应
- 批准号:32371454
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于抗原抗体相互作用的抗体定向虚拟设计与筛选
- 批准号:32370697
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
单个抗体IgG在图案化抗原阵列上运动的可视化研究
- 批准号:32301180
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
CD40-CD154共刺激信号介导的TD/TI抗原诱导罗非鱼抗体分泌细胞形成机制的比较研究
- 批准号:32303044
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
A Wholly Protein-based Self-assembly Nanoplatform for TNBC-specific Combination Therapy
用于 TNBC 特异性联合治疗的完全基于蛋白质的自组装纳米平台
- 批准号:
10668398 - 财政年份:2022
- 资助金额:
$ 20.24万 - 项目类别:
Synergistic combinatorial DNA damage response/repair inhibition and Sacituzumab Govitecan in triple-negative breast cancer
三阴性乳腺癌中协同组合 DNA 损伤反应/修复抑制和 Sacituzumab Govitecan
- 批准号:
10390503 - 财政年份:2022
- 资助金额:
$ 20.24万 - 项目类别:
Molecular mechanisms of T cell responses to a clonal neoantigen resulting from a mutated driver oncogene.
T 细胞对由突变的驱动癌基因产生的克隆新抗原作出反应的分子机制。
- 批准号:
10185280 - 财政年份:2021
- 资助金额:
$ 20.24万 - 项目类别:
Molecular mechanisms of T cell responses to a clonal neoantigen resulting from a mutated driver oncogene.
T 细胞对由突变的驱动癌基因产生的克隆新抗原作出反应的分子机制。
- 批准号:
10363712 - 财政年份:2021
- 资助金额:
$ 20.24万 - 项目类别: